Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 8029-8040 of 8077

Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine

Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023

PR Newswire associated0

Scivita Medical Single-use Broncho Videoscope Solution Showcased at ERS 2023

PR Newswire associated0

Microbiome Insights, Inc. Releases Updated Guide for Researchers Planning and Conducting Microbiome Studies

PR Newswire associated0

J INTS BIO, WCLC 2023 - Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI

PR Newswire associated0

Medac GmbH Advances Pharmacovigilance Technology for Safety Monitoring of its Drugs with ArisGlobal Solutions

Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China

PR Newswire associated0

Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets

PR Newswire associated0

New Study Evaluates How Quickly the Migraine Preventive Impact of Nerivio® Starts

PR Newswire associated0

"Promoting Health, Wellness, and Community: Gowalking.com Unites Global Fitness Walkers for a Better World"

ACCESSWIRE logo

Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot

Dan and Steve McCabe

The Big Blue Bus Stops at the Palace of Westminster to celebrate International Heart Valve Disease Awareness Week

  • Prev Page
  • 1
  • 2
  • …
  • 669
  • 670
  • 671
  • …
  • 673
  • 674
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us